Energy

At a Glance

Overview

The Basics

Energy is an outcome label, not one mechanism.

This collection groups together the compounds most often attached to mitochondrial and metabolic energy conversations, but they do not belong to one clean biochemical family. Three entries are actual peptides: SS-31, Humanin, and MOTS-C. Four are not peptides: 5-Amino-1MQ, BAM15, NAD+, and SLU-PP-332. The taxonomy also includes blend pages and a duplicate uncoupler label.

The practical value of the page is lane separation:

• mitochondrial peptide lane
• metabolic-signaling lane
• uncoupler lane
• blend lane

That structure is more useful than calling everything here an energy peptide.

The Science

The mitochondrial peptide lane centers on SS-31, Humanin, and MOTS-C, but each member solves a different problem. SS-31 stabilizes cardiolipin and mitochondrial membrane architecture. Humanin is a mitochondrial-derived cytoprotective peptide linked to apoptosis control and stress resistance. MOTS-C is a mitochondrial-derived signaling peptide that pushes AMPK-linked metabolic adaptation and mitochondrial biogenesis.

The metabolic-signaling lane includes 5-Amino-1MQ, MOTS-C, and SLU-PP-332, with NAD+ functioning as the non-peptide cofactor support member. 5-Amino-1MQ works through NNMT inhibition and the NAD+/sirtuin axis. SLU-PP-332 works through ERR agonism and transcriptional upregulation of oxidative metabolism. NAD+ is not a signaling peptide, but it supports the redox economy that mitochondrial throughput depends on.

The uncoupler lane is BAM15, with bam-15 as a legacy duplicate label for the same small molecule. That lane is distinct because uncoupling increases energy expenditure by dissipating the proton gradient rather than by repairing mitochondria, adding cofactors, or changing transcriptional signaling.

The blend lane contains SLU-PP-332 + 5-Amino and SLU-PP-332 + BAM15, with a second legacy duplicate for the BAM15 blend. Those entries exist because the market and the community package these mechanisms together, not because the combinations have independent clinical validation.

How It Works / Synergy Analysis

The Basics

The cleanest interpretation of this collection is mechanism first and stack logic second.

Real overlap exists, but it is not uniform:

• SS-31 and MOTS-C form the clearest mitochondrial hardware-plus-signaling pair
• Humanin belongs beside them as the mitochondrial stress-resilience member
• 5-Amino-1MQ, SLU-PP-332, and NAD+ cluster around metabolic efficiency and mitochondrial support without sharing one direct mechanism
• BAM15 stands apart as the uncoupler
• the blend entries reflect commercial packaging of the above logic

The Science

SS-31 plus MOTS-C is the strongest genuine mechanism complement in the collection. SS-31 repairs mitochondrial hardware by binding cardiolipin and protecting cristae structure. MOTS-C changes mitochondrial software by activating AMPK-linked metabolic adaptation and mitochondrial biogenesis.

Humanin can fit beside that pair, but through a different role. It is less about immediate output and more about cytoprotection, mitophagy, and apoptosis regulation under metabolic stress. That makes it mitochondrial, but not interchangeable with SS-31 or MOTS-C.

5-Amino-1MQ and SLU-PP-332 are best read as metabolic-signaling tools rather than as mitochondrial repair tools. 5-Amino-1MQ changes the NNMT/NAD+ context that shapes fuel handling. SLU-PP-332 changes ERR-driven transcription of oxidative genes and mitochondrial biogenesis. NAD+ can support both lanes as a non-peptide cofactor, but it does not validate every stack built around it.

BAM15 belongs in its own lane because uncoupling changes energy balance by making mitochondria burn substrate less efficiently for ATP production. That is mechanistically interesting and metabolically powerful, but it is not the same claim as mitochondrial repair or mitochondrial biogenesis.

The blend entries therefore have only conceptual synergy:

• SLU-PP-332 + 5-Amino = transcriptional metabolic programming plus NNMT/NAD+ salvage support
• SLU-PP-332 + BAM15 = mitochondrial biogenesis logic plus uncoupling logic

Those combinations are real motifs in community practice. The local KB does not support normalizing them as default energy protocols.

Key Benefits & Goals

The Basics

This collection is strongest when it separates energy conversations into narrower goals:

• mitochondrial hardware support
• mitochondrial stress resilience
• metabolic flexibility and endurance signaling
• redox and cofactor support
• uncoupling-driven energy expenditure
• marketed blend navigation

That separation keeps "energy" from collapsing into one vague promise.

The Science

The clearest benefits by lane are:

• SS-31 for cardiolipin support, mitochondrial efficiency, and cleaner baseline energy framing
• Humanin for cytoprotection, mitochondrial stress signaling, and age-related resilience framing
• MOTS-C for AMPK-driven metabolic flexibility, endurance support, and exercise-mimetic signaling
• 5-Amino-1MQ for NNMT-linked metabolic support and NAD+-adjacent energy framing
• NAD+ for cofactor support, cellular-energy handling, and cognitive-clarity narratives
• SLU-PP-332 for ERR-driven endurance and oxidative-capacity framing
• BAM15 for uncoupler-driven body-composition and energy-expenditure interest

The weaker or more inference-heavy benefits are:

• broad anti-aging claims from Humanin
• dramatic fat-loss certainty from 5-Amino-1MQ, MOTS-C, or SLU-PP-332
• casual safety assumptions around BAM15
• proof that blend pages represent better protocols than the single-agent guides

Evidence Summary

The Basics

The evidence base here is uneven and mechanistically fragmented.

SS-31 has the strongest direct mitochondrial identity and the strongest clinical footing in the set because elamipretide has disease-specific FDA approval in Barth syndrome. MOTS-C has strong mechanistic relevance and a recognizable role in mitochondrial discussions, but the therapeutic evidence remains mostly preclinical. NAD+ has high biological relevance but messy real-world protocol evidence. 5-Amino-1MQ, SLU-PP-332, and BAM15 are interesting metabolic compounds with animal-heavy evidence and community-level confounding. Humanin is scientifically important in mitochondrial peptide biology, but the human therapeutic signal is still thin.

The blend pages sit below all of those on the evidence ladder because their rationale is derivative.

The Science

Evidence calibration across the collection:

• Most direct mitochondrial and clinical footing: SS-31
• Best peptide-signaling bridge between energy and metabolism: MOTS-C
• Strongest broad cofactor plausibility but variable protocol quality: NAD+
• Promising preclinical metabolic-signaling compounds: 5-Amino-1MQ, SLU-PP-332
• Preclinical uncoupler with distinct safety framing: BAM15
• Mitochondrial peptide with important biology but low standalone clinical translation: Humanin
• Most weakly supported as independent evidence objects: SLU-PP-332 + 5-Amino, SLU-PP-332 + BAM15, and the bam-15 alias layer

This hierarchy matters because the page would otherwise overstate the certainty of the entire energy category.

Component Highlights

Quick links: 5-Amino-1MQ, BAM15, Humanin, MOTS-C, NAD+, SLU-PP-332, SS-31, SLU-PP-332 + 5-Amino, SLU-PP-332 + BAM15.

5-Amino-1MQ

5-Amino-1MQ is the NNMT-inhibition member of the collection. It is not a peptide. Its energy relevance comes from metabolic reprogramming and NAD+-salvage support rather than from direct mitochondrial repair.

BAM15

BAM15 is the uncoupler member. It is not a peptide. bam-15 is a legacy duplicate label for the same concept, so the guide treats both taxonomy entries as one compound family entry.

Humanin

Humanin is the mitochondrial stress-resilience peptide. It matters because energy decline is not only about throughput; it is also about whether cells survive metabolic stress without drifting into dysfunction.

MOTS-C

MOTS-C is the metabolic-signaling peptide. It is the clearest exercise-mimetic and AMPK-centered member in the set, and it bridges the mitochondrial peptide lane with the metabolic-signaling lane.

NAD+

NAD+ is the cofactor-support member. It is not a peptide. It belongs here because energy systems depend on redox capacity, but it should not be described as equivalent to a mitochondrial peptide.

SLU-PP-332

SLU-PP-332 is the ERR-agonist member. It is not a peptide. Its role is transcriptional metabolic programming, especially around oxidative capacity and endurance-style adaptation.

SS-31

SS-31 is the mitochondrial hardware member and the collection anchor. It is the clearest fit when the conversation is specifically about cardiolipin integrity and damaged mitochondrial structure.

Blend Pages

The blend entries are SLU-PP-332 + 5-Amino and SLU-PP-332 + BAM15, with a second BAM15 blend alias also present in taxonomy. These belong in the page as navigation endpoints, not as proof of validated combined protocols.

Comparative Analysis

The Basics

The shortest useful comparison is:

• SS-31 = mitochondrial hardware
• Humanin = mitochondrial stress resilience
• MOTS-C = mitochondrial signaling and exercise-mimetic adaptation
• NAD+ = cofactor and redox support
• 5-Amino-1MQ = NNMT-linked metabolic reprogramming
• SLU-PP-332 = ERR-driven endurance and oxidative programming
• BAM15 = uncoupling and energy dissipation
• blend pages = packaged stack logic

That frame is more accurate than treating every member as a generic energy peptide.

The Science

The lane comparison can be stated directly:

• For direct mitochondrial structure support: SS-31
• For mitochondrial peptide signaling: MOTS-C
• For mitochondrial stress-response biology: Humanin
• For non-peptide fuel and redox support: NAD+
• For NNMT and adipocyte-metabolism pressure: 5-Amino-1MQ
• For ERR transcriptional endurance programming: SLU-PP-332
• For uncoupling-driven metabolic expenditure: BAM15
• For commercial combination logic: the blend entries

The main non-overlap matters as much as the overlap. Repair, signaling, cofactor support, transcriptional programming, and uncoupling are related only at a high level.

Getting Started

The Basics

The clearest entry frame is category separation before member comparison.

This page makes the most sense when the underlying question is first narrowed to mitochondrial hardware, mitochondrial signaling, metabolic inflexibility, cofactor depletion, uncoupling, or blend-page navigation. That keeps the page from turning into one oversized energy stack.

The Science

A practical orientation sequence for this collection is:

1. separate actual peptides from non-peptides;
2. separate direct mitochondrial support from metabolic-signaling support;
3. isolate the uncoupler lane from the rest of the energy category;
4. treat blend pages as derivative of the single-agent pages rather than more advanced evidence objects.

That structure preserves mechanism clarity and keeps the strongest caution around the highest-risk lane.

General Dosing Considerations

The Basics

This collection is not suitable as a dosing template because it spans:

• injectable peptides
• a coenzyme used in IV, IM, or SC wellness protocols
• oral and injectable small molecules
• a preclinical uncoupler with no established human dosing standard
• pre-mixed blend pages that inherit uncertainty from both components

Those are different dosing worlds.

The Science

The main dose-framing differences are:

• SS-31 often follows loading then maintenance logic
• MOTS-C has unusually wide protocol variability across sources
• Humanin has thin practical dosing data and weak human validation
• NAD+ requires slow titration because side effects rise quickly with aggressive dosing
• 5-Amino-1MQ has oral and injectable protocol noise with no human trial anchor
• SLU-PP-332 has sharp disconnects between circulating community doses and preclinical scaling logic
• BAM15 has only preclinical dose data and should not be treated like a normal wellness peptide

This is another reason the blend lane should not be normalized.

What to Expect

The Basics

Readers should not expect one uniform energy effect from this collection.

Some members are gradual and structural. Some are more metabolic and endurance-oriented. Some create subjectively noticeable energy. Some mainly exist in the knowledge graph because the market packages them into blends. Subjective energy and mitochondrial repair are not the same observation.

The Science

The most useful expectation split is:

• SS-31: gradual mitochondrial-efficiency and recovery-style changes
• Humanin: subtle resilience framing with limited standalone felt-effect signal
• MOTS-C: endurance, work-capacity, and metabolic-flexibility changes that may build over weeks
• NAD+: quicker energy or clarity signals for some users, with equally quick tolerability issues when overdosed
• 5-Amino-1MQ: often subtle energy support before any visible body-composition shift
• SLU-PP-332: early energy and warmth signals in community reports, with crash risk at higher doses
• BAM15: body-composition and heat-expenditure framing rather than a clean peptide-style energy story

The blend pages inherit all of those uncertainties rather than simplifying them.

Safety & Interactions

The Basics

The main safety issue in this collection is false equivalence.

These members do not share one risk profile, one evidence tier, or one chemistry class. The page becomes misleading as soon as the uncoupler lane or the blend lane is treated like a casual extension of mitochondrial peptide support.

The Science

Key collection-level cautions:

• 5-Amino-1MQ, BAM15, NAD+, and SLU-PP-332 are not peptides.
• BAM15 is the uncoupler lane and deserves the strongest caution against casual stacking or extrapolated human dosing confidence.
• NAD+ can produce nausea, palpitations, insomnia, and methylation-related tolerability problems when pushed too hard.
• MOTS-C remains investigational, and community use repeatedly flags injection-site pain, histamine-style reactions, and variable response quality.
• Humanin has fundamental pathway relevance around apoptosis and stress signaling, but long-term human safety remains largely undefined.
• 5-Amino-1MQ and SLU-PP-332 are heavily confounded in community logs because they are often paired with GLP-1s, GH-axis agents, stimulants, or each other.
• SLU-PP-332 + BAM15 and SLU-PP-332 + 5-Amino are marketed blends, not collection-endorsed defaults.
• bam15 and bam-15 should be interpreted as one concept, not as independent evidence points.

Frequently Asked Questions

Is this really a peptide page?

It is a peptide function page in app taxonomy, but not a chemistry-pure peptide page. Four of the core entries are non-peptides, and the guide states that boundary repeatedly because it affects evidence and safety interpretation.

Why are BAM15 and Bam-15 both present?

The taxonomy includes a legacy duplicate. Local normalization rules collapse bam-15 into BAM15, so the guide uses BAM15 as the canonical body label while acknowledging the duplicate slug.

Which members are most directly mitochondrial?

SS-31 is the most direct structural mitochondrial member. MOTS-C and Humanin are the most direct mitochondrial-derived peptide members. NAD+, 5-Amino-1MQ, and SLU-PP-332 are mitochondrial-adjacent through metabolism and signaling rather than direct membrane repair.

Which lane is most speculative as a routine stack?

The blend lane. It reflects community and vendor packaging, but it does not carry the same level of direct evidence as the single-agent pages.

Which member needs the strongest normalization restraint?

BAM15, because uncoupling is mechanistically distinct, preclinical-only, and easy to over-read as a shortcut.

Which entries are not peptides?

5-Amino-1MQ, BAM15, NAD+, and SLU-PP-332 are not peptides. The blend pages inherit that mixed chemistry rather than resolving it.

Related Guides

Core Members

• 5-Amino-1MQ
• BAM15
• Humanin
• MOTS-C
• NAD+
• SLU-PP-332
• SS-31

Blend Pages

• SLU-PP-332 + 5-Amino
• SLU-PP-332 + BAM15

Related Collections in This KB

• Mitochondrial Optimization Stack
• Longevity Stack
• Non-GLP-1 Weight Loss Peptides